These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9537053)
1. Determination of the immunoglobulin class of complement-dependent cytotoxic antibodies in serum of D23 hepatoma-bearing rats. Lando P; Gabriel J; Berzins K; Perlmann P Scand J Immunol; 1980; 11(3):253-60. PubMed ID: 9537053 [TBL] [Abstract][Full Text] [Related]
2. Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats. Lando P; Berzins K; Gabriel J; Larsson P; Perlmann P Br J Cancer; 1981 Oct; 44(4):522-31. PubMed ID: 7295508 [TBL] [Abstract][Full Text] [Related]
3. Complement-dependent cytotoxicity against hepatoma cells mediated by IgM antibodies in serum from tumor-bearing rats. Lando P; Blomberg F; Raftell M; Berzins K; Perlmann P Scand J Immunol; 1977; 6(11):1081-92. PubMed ID: 202015 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of tumour-bearer serum to D23 hepatoma cells derived from solid tumours, ascites or in vitro cultures. Lando P; Gabriel J; Berzins K; Perlmann P Scand J Immunol; 1982 Mar; 15(3):259-66. PubMed ID: 7089487 [TBL] [Abstract][Full Text] [Related]
5. The lipid nature of a tumour-associated autoantigen from a chemically induced rat hepatoma. Lando P; Berzins K; Perlmann P Scand J Immunol; 1982 Feb; 15(2):187-93. PubMed ID: 6179153 [TBL] [Abstract][Full Text] [Related]
6. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1. Boyle MD; Langone JJ J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124 [TBL] [Abstract][Full Text] [Related]
7. Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity. Hannant D; Bowen JG; Price MR; Baldwin RW Br J Cancer; 1980 May; 41(5):716-23. PubMed ID: 6158964 [TBL] [Abstract][Full Text] [Related]
8. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC). Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836 [TBL] [Abstract][Full Text] [Related]
9. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244 [TBL] [Abstract][Full Text] [Related]
10. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes. Miletic VD; Hester CG; Frank MM J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829 [TBL] [Abstract][Full Text] [Related]
11. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma. Price MR; Baldwin RW Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028 [TBL] [Abstract][Full Text] [Related]
12. Purification, identification and elimination of a natural human serum antibody with cytotoxic effect on guinea pig thymocytes. Sandberg G; Rydlander L; Stenvinkel C Int Arch Allergy Appl Immunol; 1987; 83(1):57-63. PubMed ID: 3106242 [TBL] [Abstract][Full Text] [Related]
14. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity. Watier H; Guillaumin JM; Piller F; Lacord M; Thibault G; Lebranchu Y; Monsigny M; Bardos P Transplantation; 1996 Jul; 62(1):105-13. PubMed ID: 8693523 [TBL] [Abstract][Full Text] [Related]
15. Complement-dependent cytotoxic antitumor antibody. I. Immunoglobulin class determined by interaction with protein A or concanavalin A. Langone JJ; Boyle MD; Borsos T J Natl Cancer Inst; 1978 Feb; 60(2):411-8. PubMed ID: 202718 [No Abstract] [Full Text] [Related]
16. Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system. Medgyesi GA; Miklós K; Kulics J; Füst G; Gergely J; Bazin H Immunology; 1981 May; 43(1):171-6. PubMed ID: 7251048 [TBL] [Abstract][Full Text] [Related]
17. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. Shouval D; Wands JR; Zurawski VR; Isselbacher KJ; Shafritz DA Proc Natl Acad Sci U S A; 1982 Jan; 79(2):650-4. PubMed ID: 6952217 [TBL] [Abstract][Full Text] [Related]
18. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. Sarmiento M; Glasebrook AL; Fitch FW J Immunol; 1980 Dec; 125(6):2665-72. PubMed ID: 6159417 [TBL] [Abstract][Full Text] [Related]
19. Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors. Gregoriadis G; Meehan A; Mah MM Biochem J; 1981 Nov; 200(2):203-10. PubMed ID: 6803776 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Masui H; Moroyama T; Mendelsohn J Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]